Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Yahoo Finance Results

    2. Is Bristol-Myers Squibb Company’s (BMY) ROE Of 30.51% Sustainable?

      Simply Wall St. via Yahoo FinanceOct 09 13:19 PM

      Bristol-Myers Squibb Company (NYSE:BMY) delivered an ROE of 30.51% over the past 12 months, which is an impressive feat relative to its industry average of 18.27% ...

    3. Stillwater, MN, based Investment company Stillwater Investment Management, LLC buys DowDuPont Inc, Bristol-Myers Squibb Company during the 3-months ended 2017-09-30, according to the most recent filings ...

    4. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BMY. Over the last one-month, outflows of investor capital in ETFs holding BMY totaled ...

    5. CHAPEL HILL, N.C , Oct. 12, 2017 /PRNewswire/ -- TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic partnership ...

    6. Bristol-Myers Squibb Company announced that it has appointed scientific and business thought-leader, Saurabh Saha, M.D., Ph.D., as senior vice president and global ...

    7. Exelixis, Inc. today announced that it has earned a $10 million milestone payment from Bristol-Myers Squibb under the terms of the two companies’ worldwide collaboration ...

    8. Bristol-Myers Squibb Company BMY extended its strategic partnership with TARGET PharmaSolutions, Inc. The partnership has been extended for TARGET-NASH for a multi-year ...

    9. Cramer's lightning round: Zagg's got good swag

      CNBC via Yahoo FinanceOct 12 22:51 PM

      I think there's a lot to the company." Bristol-Myers Squibb Co. (NYSE: BMY) : "Bristol-Myers came all the way back [and] made a new high despite the ...

    10. Bristol-Myers Squibb Company , in collaboration with Blue Faery: The Adrienne Wilson Liver Cancer Association, a leading liver cancer patient advocacy organization ...

    11. Here's What's Has Happened in the HCV Space Lately

      Zacks via Yahoo FinanceOct 06 20:10 PM

      GILD markets blockbuster HCV drugs, Sovaldi and Harvoni, while other well-known names in this market are AbbVie Inc.’s ABBV Viekira Pak, Bristol-Myers’ BMY Daklinza and Johnson ...

    1. Ad
      related to Bristol Myers Squibb Company